Skip to main content
. 2017 May 26;8(43):74139–74158. doi: 10.18632/oncotarget.18274

Table 3. The characteristics of included PTC patients (TCGA dataset, N = 449).

Pathological parameters No. of patients N (%)
Age < 45 198 (45.3)
≥ 45 239 (54.7)
Gender Male 122 (27.9)
Female 315 (72.1)
Tumor subtypes Classical/Usual 310 (70.9)
Tall cell 33 (7.6)
Follicular 89 (20.4)
Others 5 (1.1)
History of other tumor No 406 (94.2)
Yes 25 (5.8)
Pathological stage I–II 285 (65.5)
III–IV 150 (34.5)
T stage T1–T2 264 (60.4)
T3–T4 173 (39.6)
N stage Nx–N0 236 (54.0)
N1 201 (46.0)
M stage M0 428 (98.2)
M1 8 (1.8)
Focus types Unifocal 228 (53.3)
Multifocal 200 (46.7)
Extrathyroidal extension No 280 (66.2)
Yes 143 (33.8)
BRAFV600E Mutation type 212 (48.5)
Wild type 225 (51.5)